论文部分内容阅读
治疗胆石症和胆道感染的新药胆益宁1984年3月底由浙江省卫生厅、商业厅主持在温州市通过技术鉴定。胆益宁是以中草药为主成分的片剂,由温州生化药厂和温州医科所研制、浙江医科大学附属一院、二院等8个临床单位协作,经过四年的共同努力所取得的成果。动物实验表明,胆益宁能增加胆汁流量,对离体肠段平滑肌有松弛作用,对血压无影响;在试管中对多种致病菌有一定抑制作用。经313例临床疗效观察:治疗胆石症排石率为75.2%,排净率为17.4%,治疗胆道感染总有效率为95.4%,证实具有明显的利胆、排石、消炎、止痛作用,起效时间迅速,未见毒副反应。适用于急慢性胆囊炎、胆道感染、胆囊和胆道结石(包括残留结石),并可用于预防胆道结石复发。
A new drug for the treatment of cholelithiasis and biliary tract infection Bian Yinning was approved by the Zhejiang Provincial Department of Health and the Department of Commerce in Wenzhou City at the end of March 1984. BAIYINNING is a tablet based on Chinese herbal medicine. It was developed by Wenzhou Shenghua Pharmaceutical Co., Ltd. and Wenzhou Medical Institute, and cooperated with 8 clinical units including the First Affiliated Hospital and the Second Affiliated Hospital of Zhejiang Medical University. After four years of joint efforts, the results were achieved. . Animal experiments have shown that gallbladder can increase bile flow, relax the isolated smooth muscles of the intestine, and have no effect on blood pressure; it can inhibit a variety of pathogenic bacteria in test tubes. After 313 cases of clinical curative effect observations: the rate of stone treatment for cholelithiasis was 75.2%, the rate of rejection was 17.4%, and the total effective rate for the treatment of biliary tract infection was 95.4%. It was confirmed that it has obvious functions of gallbladder, row of stone, anti-inflammatory and analgesic. The effect time was rapid and no toxic side effects were seen. Suitable for acute and chronic cholecystitis, biliary tract infections, gallbladder and bile duct stones (including residual stones), and can be used to prevent the recurrence of bile duct stones.